Ha, G. et al. (2023) “Are patients with HHV-8 associated Castleman disease successfully treated with rituximab at risk of subsequently developing HHV-8 negative (idiopathic) Castleman disease? iMCD after HHV-8-associated MCD”, European Journal of Case Reports in Internal Medicine, 10(7). doi:10.12890/2023_003904.